[Editor’s note: This post is excerpted from this week’s forthcoming NORML weekly media advisory. To…
Tag: DEA
Again, next time you hear or read about law enforcement or federal anti-drug agencies employing…
It’s the ‘Catch-22’ that has plagued medical marijuana advocates and patients for decades. Lawmakers and health regulators demand clinical studies on the safety and efficacy of medical cannabis, but the federal agency in charge of such research bars these investigations from ever taking place.
You can’t get more mainstream in the media than The New York Times and Wall Street Journal, who both highlight the growing medical acceptance of medical cannabis and the uber-political conditions placed on medical researchers who want to conduct rigorous scientific studies on cannabis’ medical efficacy and safety.
The United States federal government has supplied Rosenfeld and three other US citizens for decades with a smokable cannabis medicine. Irv Rosenfeld has received his medicine for 27 years and is the longest known cannabis patient.
Today the AMA voted to reverse its longstanding endorsement of cannabis’ Schedule I prohibitive status. The vote took place during the organization’s annual Interim Meeting of the House of Delegates in Houston, Texas, and marks the first time that the AMA has revisited its position on cannabis in eight years.
They’ll tell you that if hemp were legal, growers of illicit high-THC pot would hide their crops in-between the rows of hemp. Any farmer can tell you that what you’d get is cross-pollination; the hemp would ruin the high of the pot and the pot would ruin the strength of the hemp.
For nearly two decades Emery operated a successful marijuana seed bank operation in Vancouver, British Columbia — a venture which he used to directly fund cannabis law reform efforts around the globe, including the magazine Cannabis Culture, the internet site Pot TV, and the founding of the British Columbia Marijuana Party.